TrialPharmacology research & perspectives2023

A phase I, first-in-human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937.

Paul D Benn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.